IL-7 Protein 207-IL-005 from R&D Systems, a Bio-Techne Brand

Product Specs
ItemIL-7 Protein
CompanyR&D Systems, a Bio-Techne Brand
Price $325.00Supplier Page View Company Product Page
Catalog Number207-IL-005
SpeciesHuman
Molecule NameIL-7
Size5 ug (also 10 ug, 25 ug, 50 ug, 200 ug)
ApplicationsBioactivity
Conjugate/TagUnconjugated
Source/Expression SystemE. coli-derived Recombinant Human IL-7 Protein
StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution
Purity>97%, by SDS-PAGE under reducing conditions and visualized by silver stain
FormatLyophilized from a 0.2 µm filtered solution in PBS with BSA as a carrier protein
NCBI Gene AliasesIL-7
NCBI Full Gene Nameinterleukin 7

Specifications/Features

Available conjugates: Sizes Available: 5 ug (also 10 ug, 25 ug, 50 ug, 200 ug)

Add to Compare List

R&D Systems, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

Company Profile

Website: http://www.rndsystems.com

(1) Temporal variability in healthy donor IFN-γ ELISpot responses reveals a stable IL-7-responsive functional metric for immune phenotypingImmunohorizonsApril 19, 2026Annemarie Nguyen, Ruth-Ann Brown, Anthony S BonaviaCD28.2; BioLegend #302902) at 2.5 μg/mL. For IL-7 co-stimulation, recombinant human IL-7 (R&D Systems, #207IL005) was added at 50 ng/mL in combination with the anti-CD3/anti-CD28 cocktail. Plate development and analysis After

(2) Toggling of NKG2A expression drives functional specialization of iPSC-derived CAR NK cellsbioRxiv : the preprint server for biologyAugust 23, 2025Kanaya M, Philippon C, Netskar H, Saetersmoen ML, Cieslar-Pobuda A, Torralba-Raga L, Casoni GP, Hammer Q, Vincenti M, Wiiger MT, et al.

(3) Autologous HIV-specific T cell therapy targeting conserved epitopes is well-tolerated in six adults with HIV: an open-label, single-arm phase 1 studyNature communicationsMay 15, 2025Sohai DK, Keller MD, Hanley PJ, Hoq F, Kukadiya D, Datar A, Reynolds E, Copertino DC, Lazarski C, McCann CD, et al.

(4) Inhibition of histone methyltransferase EZH2 for immune interception of colorectal cancer in Lynch syndromeJCI insightFebruary 13, 2025Bowen CM, Duzagac F, Martel-Martel A, Reyes-Uribe L, Zaheer M, Thompson J, Deng N, Sinha R, Mazumdar S, Taggart MW, et al.L-glutamine, 1% penicillin/streptomycin, 1% 1 M HEPES buffer, and 330 U/ml IL-7 (R&D Systems, catalog no. 207-IL-005) for 3 days. On day 3, cells were transferred to the coculture experiment. Mouse organoid and splenocytes

(5) Human liver sinusoidal endothelial cells support the development of functional human pluripotent stem cell-derived Kupffer cellsCell reportsAugust 27, 2024Kent GM, Atkins MH, Lung B, Nikitina A, Fernandes IM, Kwan JJ, Andrews TS, MacParland SA, Keller GM, Gage BK.

(6) Molecular mimicry in multisystem inflammatory syndrome in childrenNatureAugust 1, 2024Bodansky A, Mettelman RC, Sabatino JJ Jr, Vazquez SE, Chou J, Novak T, Moffitt KL, Miller HS, Kung AF, Rackaityte E, et al.

(7) Generation and optimization of off-the-shelf immunotherapeutics targeting TCR-Vβ2+ T cell malignancyNature communicationsJanuary 15, 2024Ren J, Liao X, Lewis JM, Chang J, Qu R, Carlson KR, Foss F, Girardi M.

(8) Solar ultraviolet B radiation promotes α-MSH secretion to attenuate the function of ILC2s via the pituitary-lung axisNature communicationsSeptember 12, 2023Huang Y, Zhu L, Cheng S, Dai R, Huang C, Song Y, Peng B, Li X, Wen J, Gong Y, et al.

(9) Primary role of type I interferons for the induction of functionally optimal antigen-specific CD8(+) T cells in HIV infectionEBioMedicineMay 1, 2023Cabral-Piccin MP, Papagno L, Lahaye X, Perdomo-Celis F, Volant S, White E, Monceaux V, Llewellyn-Lacey S, Fromentin R, Price DA, et al.and prostaglandin E2 (PGE2, 1 μM, Merck, CAT#538904), together with IL-7 (0.5 ng/mL, R&D Systems, CAT#207-IL005). A combination of anti-IFN-α (20,000 NU/mL, Tebu-Bio, CAT#31101-1) and anti-IFN-β (5000 NU/mL, Tebu-Bio,

(10) Strength of CAR signaling determines T cell versus ILC differentiation from pluripotent stem cellsCell reportsMarch 28, 2023Li S, Wang CS, Montel-Hagen A, Chen HC, Lopez S, Zhou O, Dai K, Tsai S, Satyadi W, Botero C, et al.

(11) Identification of T Cell Receptors Targeting a Neoantigen Derived from Recurrently Mutated FGFR3CancersFebruary 6, 2023Tate T, Matsumoto S, Nemoto K, Leisegang M, Nagayama S, Obama K, Nakamura Y, Kiyotani K.

(12) Ageing Curtails the Diversity and Functionality of Nascent CD8(+) T Cell Responses against SARS-CoV-2VaccinesJanuary 11, 2023Proietto D, Dallan B, Gallerani E, Albanese V, Llewellyn-Lacey S, Price DA, Appay V, Pacifico S, Caputo A, Nicoli F, et al.

(13) Roles of IL-7R Induced by Interactions between Cancer Cells and Macrophages in the Progression of Esophageal Squamous Cell CarcinomaCancersJanuary 6, 2023Kitamura Y, Koma YI, Tanigawa K, Tsukamoto S, Azumi Y, Miyako S, Urakami S, Kodama T, Nishio M, Shigeoka M, et al.

(14) DLL4 and VCAM1 enhance the emergence of T cell-competent hematopoietic progenitors from human pluripotent stem cellsScience advancesAugust 26, 2022Michaels YS, Edgar JM, Major MC, Castle EL, Zimmerman C, Yin T, Hagner A, Lau C, Hsu HH, Ibañez-Rios MI, et al.

(15) EZH1 repression generates mature iPSC-derived CAR T cells with enhanced antitumor activityCell stem cellAugust 4, 2022Jing R, Scarfo I, Najia MA, Lummertz da Rocha E, Han A, Sanborn M, Bingham T, Kubaczka C, Jha DK, Falchetti M, et al.

(16) Ectopic Lymphoid Follicle Formation and Human Seasonal Influenza Vaccination Responses Recapitulated in an Organ-on-a-ChipAdvanced science (Weinheim, Baden-Wurttemberg, Germany)May 1, 2022Goyal G, Prabhala P, Mahajan G, Bausk B, Gilboa T, Xie L, Zhai Y, Lazarovits R, Mansour A, Kim MS, et al.from R&D Systems. Protein standards for recombinant IFN‐γ (#285‐IF‐100), IL‐2 (#202‐IL‐010), IL‐7 (#207‐IL‐005), IL‐10 (#217‐IL‐005), GM‐CSF (#215‐GM‐010), CXCL13 (#DY801) were all from R&D Systems. Briefly, immune

(17) Hypoxic, glycolytic metabolism is a vulnerability of B-acute lymphoblastic leukemia-initiating cellsCell reportsApril 26, 2022Morris V, Wang D, Li Z, Marion W, Hughes T, Sousa P, Harada T, Sui SH, Naumenko S, Kalfon J, et al.,R and D Systems,308-FK-005 Recombinant human thrombopoietin,R and D Systems,288-TP-005 Recombinant human interleukin-7,R and D Systems,207-IL-005 Mitotracker green,Thermo Fisher,CAS: 201860-17-5 IBET-151,SelleckChem,CAS: 1300031-49-5 3-bromopyruvate,Sigma,CAS:

(18) The Thermal Dose of Photothermal Therapy Generates Differential Immunogenicity in Human Neuroblastoma CellsCancersMarch 11, 2022Sekhri P, Ledezma DK, Shukla A, Sweeney EE, Fernandes R.

(19) Myeloid-derived suppressor cells and their association with vaccine immunogenicity in South African infantsJournal of leukocyte biologyNovember 1, 2021Kidzeru E, Gasper MA, Shao D, Edlefsen PT, Lejarcegui N, Havyarimana E, Urdahl K, Gantt S, Horton H, Jaspan H, et al.

(20) FKBP3 Induces Human Immunodeficiency Virus Type 1 Latency by Recruiting Histone Deacetylase 1/2 to the Viral Long Terminal RepeatmBioAugust 31, 2021Yang X, Zhao X, Zhu Y, Shen Y, Wang Y, Lu P, Jiang Z, Pan H, Yang J, Xun J, et al.

Be the First to Write a Review!

Recombinant Human IL-7 Protein

IL-7 Protein

IL-7 Protein

IL-7 Protein from R&D Systems, a Bio-Techne Brand

Description

Specifications/Features

R&D Systems, a Bio-Techne Brand

Citations (172)

Reviews

IL-7 Protein from R&D Systems, a Bio-Techne Brand

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map